Market Closed -
Nyse
04:00:01 2024-06-07 pm EDT
|
5-day change
|
1st Jan Change
|
187.5
USD
|
-0.96%
|
|
-1.20%
|
+23.02%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
12,564
|
11,684
|
10,421
|
10,060
|
10,405
|
12,551
|
-
|
-
|
Enterprise Value (EV)
1 |
16,487
|
14,316
|
14,496
|
14,766
|
15,198
|
17,161
|
17,045
|
16,797
|
P/E ratio
|
15.7
x
|
12.5
x
|
11
x
|
15.4
x
|
14.9
x
|
13.5
x
|
12.4
x
|
10.8
x
|
Yield
|
0.42%
|
0.15%
|
0.62%
|
0.57%
|
0.52%
|
0.43%
|
0.44%
|
0.44%
|
Capitalization / Revenue
|
1.1
x
|
1.01
x
|
0.82
x
|
0.75
x
|
0.73
x
|
0.81
x
|
0.76
x
|
0.72
x
|
EV / Revenue
|
1.45
x
|
1.24
x
|
1.15
x
|
1.1
x
|
1.06
x
|
1.1
x
|
1.04
x
|
0.96
x
|
EV / EBITDA
|
9.15
x
|
7.66
x
|
7.64
x
|
8.99
x
|
8.72
x
|
8.52
x
|
8.06
x
|
7.4
x
|
EV / FCF
|
20.5
x
|
8.79
x
|
517
x
|
56.4
x
|
29
x
|
22.2
x
|
21.5
x
|
17.1
x
|
FCF Yield
|
4.88%
|
11.4%
|
0.19%
|
1.77%
|
3.45%
|
4.5%
|
4.66%
|
5.83%
|
Price to Book
|
2.28
x
|
1.85
x
|
1.76
x
|
1.68
x
|
1.74
x
|
1.92
x
|
1.72
x
|
1.53
x
|
Nbr of stocks (in thousands)
|
87,582
|
84,982
|
80,377
|
71,410
|
68,259
|
66,929
|
-
|
-
|
Reference price
2 |
143.5
|
137.5
|
129.7
|
140.9
|
152.4
|
187.5
|
187.5
|
187.5
|
Announcement Date
|
2/26/20
|
2/25/21
|
2/24/22
|
2/27/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
11,378
|
11,559
|
12,642
|
13,399
|
14,282
|
15,574
|
16,461
|
17,415
|
EBITDA
1 |
1,802
|
1,869
|
1,896
|
1,643
|
1,743
|
2,013
|
2,116
|
2,270
|
EBIT
1 |
1,325
|
1,358
|
1,363
|
1,004
|
1,175
|
1,414
|
1,488
|
1,633
|
Operating Margin
|
11.64%
|
11.75%
|
10.78%
|
7.49%
|
8.23%
|
9.08%
|
9.04%
|
9.38%
|
Earnings before Tax (EBT)
1 |
1,066
|
1,252
|
1,293
|
866.3
|
940.4
|
1,214
|
1,277
|
1,428
|
Net income
1 |
814.9
|
944
|
991.6
|
675.6
|
717.8
|
937.2
|
983
|
1,078
|
Net margin
|
7.16%
|
8.17%
|
7.84%
|
5.04%
|
5.03%
|
6.02%
|
5.97%
|
6.19%
|
EPS
2 |
9.130
|
10.99
|
11.82
|
9.140
|
10.23
|
13.90
|
15.12
|
17.33
|
Free Cash Flow
1 |
804.4
|
1,629
|
28.04
|
262
|
524.7
|
772.2
|
794
|
980
|
FCF margin
|
7.07%
|
14.09%
|
0.22%
|
1.96%
|
3.67%
|
4.96%
|
4.82%
|
5.63%
|
FCF Conversion (EBITDA)
|
44.63%
|
87.16%
|
1.48%
|
15.95%
|
30.1%
|
38.36%
|
37.52%
|
43.17%
|
FCF Conversion (Net income)
|
98.71%
|
172.56%
|
2.83%
|
38.78%
|
73.1%
|
82.4%
|
80.77%
|
90.95%
|
Dividend per Share
2 |
0.6000
|
0.2000
|
0.8000
|
0.8000
|
0.8000
|
0.8000
|
0.8158
|
0.8263
|
Announcement Date
|
2/26/20
|
2/25/21
|
2/24/22
|
2/27/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
3,275
|
3,293
|
3,323
|
3,336
|
3,447
|
3,468
|
3,548
|
3,563
|
3,704
|
3,844
|
3,861
|
3,876
|
4,002
|
4,040
|
4,085
|
EBITDA
1 |
447
|
376.6
|
377.3
|
415.7
|
467.3
|
420.3
|
423.9
|
411.1
|
476.7
|
529.8
|
487.3
|
472.7
|
524.6
|
544.2
|
521.1
|
EBIT
1 |
313.6
|
232.9
|
233.4
|
275.9
|
261.4
|
278.7
|
280.1
|
285.4
|
331.2
|
388.8
|
338.7
|
323.7
|
363.8
|
384.7
|
361.5
|
Operating Margin
|
9.58%
|
7.07%
|
7.02%
|
8.27%
|
7.58%
|
8.04%
|
7.9%
|
8.01%
|
8.94%
|
10.11%
|
8.77%
|
8.35%
|
9.09%
|
9.52%
|
8.85%
|
Earnings before Tax (EBT)
1 |
306.7
|
200
|
209.7
|
234.2
|
222.3
|
214.1
|
224.7
|
220.5
|
281.1
|
336.1
|
295
|
274.9
|
317.4
|
319.9
|
307.5
|
Net income
1 |
239.1
|
153.9
|
164.1
|
182.8
|
174.8
|
163.1
|
171.3
|
167
|
216.4
|
261.8
|
224.8
|
204.5
|
246.3
|
255.2
|
240.8
|
Net margin
|
7.3%
|
4.67%
|
4.94%
|
5.48%
|
5.07%
|
4.7%
|
4.83%
|
4.69%
|
5.84%
|
6.81%
|
5.82%
|
5.28%
|
6.15%
|
6.32%
|
5.89%
|
EPS
2 |
3.000
|
2.020
|
2.200
|
2.500
|
2.430
|
2.280
|
2.420
|
2.400
|
3.160
|
3.820
|
3.261
|
3.077
|
3.744
|
3.947
|
3.630
|
Dividend per Share
2 |
0.2000
|
0.2000
|
0.2000
|
0.2000
|
0.2000
|
0.2000
|
0.2000
|
0.2000
|
0.2000
|
-
|
0.2000
|
0.2000
|
0.2000
|
0.2021
|
0.2028
|
Announcement Date
|
2/24/22
|
4/25/22
|
7/25/22
|
10/25/22
|
2/27/23
|
4/25/23
|
7/25/23
|
10/25/23
|
2/27/24
|
4/24/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
3,923
|
2,632
|
4,075
|
4,705
|
4,793
|
4,609
|
4,494
|
4,246
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.177
x
|
1.408
x
|
2.149
x
|
2.864
x
|
2.749
x
|
2.29
x
|
2.124
x
|
1.871
x
|
Free Cash Flow
1 |
804
|
1,629
|
28
|
262
|
525
|
772
|
794
|
980
|
ROE (net income / shareholders' equity)
|
16.4%
|
16%
|
16%
|
12.2%
|
11.9%
|
14.6%
|
14.6%
|
14.8%
|
ROA (Net income/ Total Assets)
|
7.78%
|
7.51%
|
7.46%
|
5.49%
|
5.23%
|
6.59%
|
6.83%
|
7.15%
|
Assets
1 |
10,477
|
12,573
|
13,284
|
12,299
|
13,731
|
14,220
|
14,402
|
15,072
|
Book Value Per Share
2 |
62.80
|
74.30
|
73.80
|
83.80
|
87.70
|
97.90
|
109.0
|
123.0
|
Cash Flow per Share
2 |
16.20
|
27.60
|
10.60
|
13.50
|
18.10
|
22.10
|
24.40
|
-
|
Capex
1 |
634
|
731
|
856
|
734
|
743
|
898
|
928
|
954
|
Capex / Sales
|
5.57%
|
6.33%
|
6.77%
|
5.48%
|
5.2%
|
5.77%
|
5.64%
|
5.48%
|
Announcement Date
|
2/26/20
|
2/25/21
|
2/24/22
|
2/27/23
|
2/27/24
|
-
|
-
|
-
|
Last Close Price
187.5
USD Average target price
194.2
USD Spread / Average Target +3.56% Consensus |
1st Jan change
|
Capi.
|
---|
| +23.02% | 12.55B | | +24.66% | 88.38B | | -21.76% | 77.56B | | +8.45% | 26.97B | | +7.94% | 18.45B | | -13.50% | 16.57B | | +77.51% | 13.65B | | +76.96% | 13.06B | | +4.72% | 12.61B | | +36.67% | 12.56B |
Other Healthcare Facilities & Services
|